Navigation Links
Moravia Worldwide to Present Webinar on Life Sciences Translation 101
Date:2/23/2010

Translation Process Optimization and Automation Tools in Life Sciences

Brno, Czech Republic (PRWEB) February 23, 2010 -- Moravia Worldwide, a leading globalization solution provider, is pleased to announce it will host a free live webinar titled "Life Sciences Translation 101". This webinar will address translation process optimization and automation opportunities that exist for life sciences companies that translate their content for international regulatory compliance.

Presented by Richard Chin, Moravia's Life Sciences Practice Lead, and Rustin Gibbs, Moravia's Solution Architect, the webinar will provide practical, actionable insights that life sciences companies can use to optimize their translation processes, automate activities, and to improve quality and manage costs.

Scheduled for Tuesday March 16, 2010, this 60-minute webinar will map out the key aspects of the regulatory environment that drive translation requirements in the medical device and pharmaceutical industries, and will focus on the current best practices in document localization in the industry. It will cover key aspects such as:

 
  • Glossaries
  • Checklist for Writing
  • Content Management
  • Automation Tools (Authoring, Terminology Management, Translation Memory, Workflow Management, Quality Management, Reporting)

It will then address the existing best practices for software localization in life sciences, including:

 
  • Unicode
  • XML
  • Automation Tools (Software Development, Testing and Validation)

The webinar will be held on Tuesday, March 16, 2010 at 11:00 EDT (8:00 PDT, 17:00 CET). Space is limited. Reserve your webinar seat now. After registering you will receive a confirmation email containing information about joining the webinar.

Through our dedicated Life Sciences Practice, Moravia is helping life sciences and healthcare companies reach global markets and satisfy local regulatory requirements by providing translation and localization services that support their efforts - from clinical trials to product launch.

About Moravia Worldwide:
Moravia Worldwide is a leading globalization solution provider, enabling companies in the information technology, e-learning, life sciences and financial industries to enter global markets with high quality multilingual products. Moravia's solutions include localization and product testing services, internationalization, multilingual publishing, technical translation and content creation. With dedicated testing and engineering solutions, Moravia helps companies release their software and hardware products globally by providing services that include test development, localization and functional testing, test automation and software engineering. Moravia Worldwide maintains global headquarters in the Czech Republic and North American headquarters in California, with local offices and production centers in Japan, China, Latin America, Ireland, USA and throughout Europe. To learn more, please visit http://www.moraviaworldwide.com.

###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3634254.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization
2. Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China
3. Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK
4. AntiBiggestLoser.com; New Blog Takes Aim at Worldwide Reality TV Show, "The Biggest Loser"
5. Kiwanis Selects Three Finalists for Worldwide Service Project
6. Rotavirus Vaccine Could Save Millions of Children Worldwide
7. Orphans International Worldwide Haiti Near Jacmel to Grow After Earthquake
8. Rotary Clubs Worldwide Mobilize To Help Meet the Massive Need for Humanitarian Aid in Haiti
9. Arab Health 2010 to See Worldwide Launch of New Women's Foot Toning Device
10. Incorrect Cell Lines Used for Worldwide Cancer Research
11. American Red Cross and HOPE worldwide Partner for MLK Day of Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... 2017 , ... Studies show evidence that carotenoids and antioxidants derived either from ... these patients. , But how often do ophthalmologists and optometrists in Sweden recommend the ... of or with early symptoms of AMD? A study published recently in ...
(Date:6/23/2017)... ... 2017 , ... Everybody has their own personal preference when it comes to ... some people don't like it at all. FindaTopDoc took a look at what makes ... can give readers a taste of their deepest, darkest fantasies and has the ability ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State University will ... 20. , The two-day conference is focused on advancing scientific knowledge about the ... lives and eliminating racial breast cancer-related disparities. The conference theme is “Illuminating Actionable ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance ... With the Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more ... 2012, the Biggert-Waters Act was enacted to reflect the actual risk in flood ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... planning services to communities in the greater Chicago metropolitan area, is embarking on ... to underprivileged youth in Chicago. , Founded in 1897, Hephzibah Children’s Association is ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: